Cynthia C. Taub
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cynthia C. Taub has a total of 192 co-authors. Here are the top co-authors by number of shared publications:
- Kana Fujikura
Department of Radiology, Columbia University, New York, NY, USA
3 shared publications - Lili Zhang
Albert Einstein College of Medicine
3 shared publications - Christopher Lee
Division of Cardiology, University of California, San Francisco
2 shared publications - Dan Leslie Li
Cardiac Electrophysiology Section, Department of Internal Medicine and Cardiology, Tulane University School of Medicine, New Orleans, USA
2 shared publications David Z. Prince
Montefiore Medical Center, Bronx, New York
2 shared publications- Diana S. Wolfe
Division of Maternal Fetal Medicine, Department of Obstetrics & Gynecology and Women’s Health, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA
2 shared publications
Latest Publications
- 14 August 2026
- Published by Elsevier in Journal of the American Society of Echocardiography
- Vol. 39 (11) , 1094-1096
The Impact of High-Altitude Training on Cardiac Performance in Adolescent Athletes
- 14 August 2026
- Published by Elsevier in Journal of the American Society of Echocardiography
- Vol. 39 (11) , 1094-1096
The Impact of High-Altitude Training on Cardiac Performance in Adolescent Athletes
- Open Access
- 19 May 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (10) , e047908
Glucose Disposal Rate: A Novel Measure of Insulin Resistance Associated With Myocardial Fibrosis and Incident Heart Failure
Background: Heart failure (HF) is increasingly driven by cardiometabolic risk factors such as obesity and insulin resistance. The estimated glucose disposal rate (eGDR) is a validated surrogate marker of insulin resistance. Reduced eGDR, reflecting higher insulin resistance, has been linked to cardiovascular disease, but its associations with myocardial fibrosis and HF remain unclear. Methods: The study included 6025 participants in MESA (Multi‐Ethnic Study of Atherosclerosis) free of HF at exam 2 (2002–2004). eGDR was calculated using body mass index, hypertension, and hemoglobin A1c. Cardiac magnetic resonance imaging (2010–2012) assessed left ventricular ejection fraction and myocardial fibrosis by late gadolinium enhancement. Associations of baseline eGDR with incident HF were evaluated using Cox models, stratified by diabetes. Results: Over a mean follow‐up of 14±5 years, 404 participants developed HF. eGDR was inversely associated with incident HF (adjusted hazard ratio [HR] per unit decrease, 1.28 [95% CI, 1.22–1.35]), a relationship that persisted regardless of diabetes status and was more pronounced for HF with preserved ejection fraction (n=200; adjusted HR per unit decrease, 1.36 [95% CI, 1.27–1.45]) than HF with reduced ejection fraction (n=168; HR, 1.19 [95% CI, 1.11–1.27]). Lower eGDR was also associated with higher left ventricular ejection fraction (n=2899; β=0.16, [95% CI, 0.03–0.28]) and higher odds of myocardial fibrosis (n=1780; adjusted odds ratio, 1.27 [95% CI, 1.16–1.41]). Conclusions: Lower eGDR is independently associated with subclinical myocardial damage and incident HF, highlighting insulin resistance as a key driver of adverse remodeling and a potential marker for early HF risk stratification and prevention.
- 19 May 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (10) , e047908
Open AccessGlucose Disposal Rate: A Novel Measure of Insulin Resistance Associated With Myocardial Fibrosis and Incident Heart Failure
Background: Heart failure (HF) is increasingly driven by cardiometabolic risk factors such as obesity and insulin resistance. The estimated glucose disposal rate (eGDR) is a validated surrogate marker of insulin resistance. Reduced eGDR, reflecting higher insulin resistance, has been linked to cardiovascular disease, but its associations with myocardial fibrosis and HF remain unclear. Methods: The study included 6025 participants in MESA (Multi‐Ethnic Study of Atherosclerosis) free of HF at exam 2 (2002–2004). eGDR was calculated using body mass index, hypertension, and hemoglobin A1c. Cardiac magnetic resonance imaging (2010–2012) assessed left ventricular ejection fraction and myocardial fibrosis by late gadolinium enhancement. Associations of baseline eGDR with incident HF were evaluated using Cox models, stratified by diabetes. Results: Over a mean follow‐up of 14±5 years, 404 participants developed HF. eGDR was inversely associated with incident HF (adjusted hazard ratio [HR] per unit decrease, 1.28 [95% CI, 1.22–1.35]), a relationship that persisted regardless of diabetes status and was more pronounced for HF with preserved ejection fraction (n=200; adjusted HR per unit decrease, 1.36 [95% CI, 1.27–1.45]) than HF with reduced ejection fraction (n=168; HR, 1.19 [95% CI, 1.11–1.27]). Lower eGDR was also associated with higher left ventricular ejection fraction (n=2899; β=0.16, [95% CI, 0.03–0.28]) and higher odds of myocardial fibrosis (n=1780; adjusted odds ratio, 1.27 [95% CI, 1.16–1.41]). Conclusions: Lower eGDR is independently associated with subclinical myocardial damage and incident HF, highlighting insulin resistance as a key driver of adverse remodeling and a potential marker for early HF risk stratification and prevention.
- Open Access
- 5 May 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (9) , e047379
Sex‐Specific Prognostic Value of Left Atrioventricular Coupling Index in Acute Coronary Syndrome: Insights From Artificial Intelligence‐Enhanced 3‐Dimensional Echocardiography
Background: Left atrioventricular coupling index (LACI) has emerged as a prognostic biomarker, but its sex‐specific relevance in acute coronary syndrome remains unclear. Methods: This retrospective cohort included 880 patients with acute coronary syndrome (625 men; 255 women) undergoing percutaneous coronary intervention between February 2022 and June 2023. LACI was automatically quantified from 3‐dimensional echocardiography using an artificial intellgience‐based dynamic heart model. Patients were stratified by sex‐specific median LACI values and followed for major adverse cardiovascular events. Cox proportional hazards and Fine–Gray competing risk models evaluated associations between LACI and outcomes. A sensitivity analysis was performed in 3 ways: (1) using propensity score matching, (2) excluding patients with atrial fibrillation, and (3) repeating propensity score matching in the cohort after excluding patients with atrial fibrillation. Results were verified in 3 independent cohorts: 285 internal validation, 124 coronary computed tomography angiography, and 128 external 3‐dimensional echocardiography cohorts. Results: Over a median 18‐month follow‐up, 219 major adverse cardiovascular events occurred. Women had significantly higher median LACI values than men. LACI was significantly associated with increased major adverse cardiovascular event risk in men (hazard ratio [HR], 1.23 [95% CI, 1.03–1.46]; P =0.020; P for interaction=0.027) but not in women. Restricted cubic spline analysis demonstrated a linear dose–response association in men. Fine–Gray analysis demonstrated a significant association between LACI and major adverse cardiovascular events in men. Findings remained consistent after AF exclusion, PSM, and across all validation cohorts. Conclusions: Artificial intelligence‐derived LACI from 3‐dimensional echocardiography demonstrates clear sex‐specific prognostic value in acute coronary syndrome, and is significantly associated with adverse cardiovascular outcomes in men but not in women. These results support sex‐specific risk stratification and highlight the clinical relevance of atrioventricular coupling assessment. Registration: URL: https://www.chictr.org.cn/ . Unique identifier: ChiCTR2500099592.
- 5 May 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (9) , e047379
Open AccessSex‐Specific Prognostic Value of Left Atrioventricular Coupling Index in Acute Coronary Syndrome: Insights From Artificial Intelligence‐Enhanced 3‐Dimensional Echocardiography
Background: Left atrioventricular coupling index (LACI) has emerged as a prognostic biomarker, but its sex‐specific relevance in acute coronary syndrome remains unclear. Methods: This retrospective cohort included 880 patients with acute coronary syndrome (625 men; 255 women) undergoing percutaneous coronary intervention between February 2022 and June 2023. LACI was automatically quantified from 3‐dimensional echocardiography using an artificial intellgience‐based dynamic heart model. Patients were stratified by sex‐specific median LACI values and followed for major adverse cardiovascular events. Cox proportional hazards and Fine–Gray competing risk models evaluated associations between LACI and outcomes. A sensitivity analysis was performed in 3 ways: (1) using propensity score matching, (2) excluding patients with atrial fibrillation, and (3) repeating propensity score matching in the cohort after excluding patients with atrial fibrillation. Results were verified in 3 independent cohorts: 285 internal validation, 124 coronary computed tomography angiography, and 128 external 3‐dimensional echocardiography cohorts. Results: Over a median 18‐month follow‐up, 219 major adverse cardiovascular events occurred. Women had significantly higher median LACI values than men. LACI was significantly associated with increased major adverse cardiovascular event risk in men (hazard ratio [HR], 1.23 [95% CI, 1.03–1.46]; P =0.020; P for interaction=0.027) but not in women. Restricted cubic spline analysis demonstrated a linear dose–response association in men. Fine–Gray analysis demonstrated a significant association between LACI and major adverse cardiovascular events in men. Findings remained consistent after AF exclusion, PSM, and across all validation cohorts. Conclusions: Artificial intelligence‐derived LACI from 3‐dimensional echocardiography demonstrates clear sex‐specific prognostic value in acute coronary syndrome, and is significantly associated with adverse cardiovascular outcomes in men but not in women. These results support sex‐specific risk stratification and highlight the clinical relevance of atrioventricular coupling assessment. Registration: URL: https://www.chictr.org.cn/ . Unique identifier: ChiCTR2500099592.
- Top Cited Papers
- 18 March 2025
- Published by Elsevier in The American Journal of Cardiology
- Vol. 246, 10-13
Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonist Use During the First Trimester in Pregnant Women With Type 2 Diabetes
- 18 March 2025
- Published by Elsevier in The American Journal of Cardiology
- Vol. 246, 10-13
Top Cited PapersEfficacy and Safety of Glucagon-like Peptide-1 Receptor Agonist Use During the First Trimester in Pregnant Women With Type 2 Diabetes
- Open Access
- 3 August 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1228613
Complications of exercise and pharmacologic stress echocardiography
Stress echocardiography is a diagnostic cardiovascular exam that is commonly utilized for multiple indications, including but not limited to the assessment of obstructive coronary artery disease, valvular disease, obstructive hypertrophic cardiomyopathy, and diastolic function. Stress echocardiography can be performed via both exercise and pharmacologic modalities. Exercise stress is performed with either treadmill or bicycle-based exercise. Pharmacologic stress is performed via either dobutamine or vasodilator-mediated (i.e., dipyridamole, adenosine) stress testing. Each of these modalities is associated with a low overall prevalence of major, life-threatening adverse outcomes, though adverse events are most common with dobutamine stress echocardiography. In light of the recent COVID-19 pandemic, the risk of infectious complications to both the patient and stress personnel cannot be negated; however, when certain precautions are taken, the risk of infectious complications appears minimal. In this article, we review each of the stress echocardiographic modalities, examine major potential adverse outcomes and contraindications, assess the risks of stress testing in the setting of a global pandemic, and examine the utilization and safety of stress testing in special patient populations (i.e., language barriers, pediatric patients, pregnancy).
- 3 August 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1228613
Open AccessComplications of exercise and pharmacologic stress echocardiography
Stress echocardiography is a diagnostic cardiovascular exam that is commonly utilized for multiple indications, including but not limited to the assessment of obstructive coronary artery disease, valvular disease, obstructive hypertrophic cardiomyopathy, and diastolic function. Stress echocardiography can be performed via both exercise and pharmacologic modalities. Exercise stress is performed with either treadmill or bicycle-based exercise. Pharmacologic stress is performed via either dobutamine or vasodilator-mediated (i.e., dipyridamole, adenosine) stress testing. Each of these modalities is associated with a low overall prevalence of major, life-threatening adverse outcomes, though adverse events are most common with dobutamine stress echocardiography. In light of the recent COVID-19 pandemic, the risk of infectious complications to both the patient and stress personnel cannot be negated; however, when certain precautions are taken, the risk of infectious complications appears minimal. In this article, we review each of the stress echocardiographic modalities, examine major potential adverse outcomes and contraindications, assess the risks of stress testing in the setting of a global pandemic, and examine the utilization and safety of stress testing in special patient populations (i.e., language barriers, pediatric patients, pregnancy).
- Open Access
- 25 May 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1155957
Outpatient intravenous diuresis in a rural setting: safety, efficacy, and outcomes
Purpose: To evaluate the safety, efficacy, and outcomes of outpatient intravenous diuresis in a rural setting and compare it to urban outcomes.Methods: A single-center study was conducted on 60 patients (131 visits) at the Dartmouth-Hitchcock Medical Center (DHMC) from 1/2021–12/2022. Demographics, visit data, and outcomes were collected and compared to urban outpatient IV centers, and inpatient HF hospitalizations from DHMC FY21 and national means. Descriptive statistics, T-tests and chi-squares were used.Results: The mean age was 70 ± 13 years, 58% were male, and 83% were NYHA III-IV. Post-diuresis, 5% had mild-moderate hypokalemia, 16% had mild worsening of renal function, and 3% had severe worsening of renal function. No hospitalizations occurred due to adverse events. The mean infusion-visit urine output was 761 ± 521 ml, and post-visit weight loss was −3.9 ± 5.0 kg. No significant differences were observed between HFpEF and HFrEF groups. 30-day readmissions were similar to urban outpatient IV centers, DHMC FY21, and the national mean (23.3% vs. 23.5% vs. 22.2% vs. 22.6%, respectively; p = 0.949). 30-day mortality was similar to urban outpatient IV centers but lower than DHMC FY21 and the national means (1.7% vs. 2.5% vs. 12.3% vs. 10.7%, respectively; p < 0.001). At 60 days, 42% of patients had ≥1 clinic revisit, 41% had ≥1 infusion revisit, 33% were readmitted to the hospital, and two deaths occurred. The clinic avoided 21 hospitalizations, resulting in estimated cost savings of $426,111.Conclusion: OP IV diuresis appears safe and effective for rural HF patients, potentially decreasing mortality rates and healthcare expenses while mitigating rural-urban disparities.
- 25 May 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1155957
Open AccessOutpatient intravenous diuresis in a rural setting: safety, efficacy, and outcomes
Purpose: To evaluate the safety, efficacy, and outcomes of outpatient intravenous diuresis in a rural setting and compare it to urban outcomes.Methods: A single-center study was conducted on 60 patients (131 visits) at the Dartmouth-Hitchcock Medical Center (DHMC) from 1/2021–12/2022. Demographics, visit data, and outcomes were collected and compared to urban outpatient IV centers, and inpatient HF hospitalizations from DHMC FY21 and national means. Descriptive statistics, T-tests and chi-squares were used.Results: The mean age was 70 ± 13 years, 58% were male, and 83% were NYHA III-IV. Post-diuresis, 5% had mild-moderate hypokalemia, 16% had mild worsening of renal function, and 3% had severe worsening of renal function. No hospitalizations occurred due to adverse events. The mean infusion-visit urine output was 761 ± 521 ml, and post-visit weight loss was −3.9 ± 5.0 kg. No significant differences were observed between HFpEF and HFrEF groups. 30-day readmissions were similar to urban outpatient IV centers, DHMC FY21, and the national mean (23.3% vs. 23.5% vs. 22.2% vs. 22.6%, respectively; p = 0.949). 30-day mortality was similar to urban outpatient IV centers but lower than DHMC FY21 and the national means (1.7% vs. 2.5% vs. 12.3% vs. 10.7%, respectively; p < 0.001). At 60 days, 42% of patients had ≥1 clinic revisit, 41% had ≥1 infusion revisit, 33% were readmitted to the hospital, and two deaths occurred. The clinic avoided 21 hospitalizations, resulting in estimated cost savings of $426,111.Conclusion: OP IV diuresis appears safe and effective for rural HF patients, potentially decreasing mortality rates and healthcare expenses while mitigating rural-urban disparities.
- Open Access
- 17 March 2023
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 10 (3) , 128
Women’s Cardiovascular Health: Prioritizing the Majority Minority
Women make up the majority of the global population, and
- 17 March 2023
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 10 (3) , 128
Open AccessWomen’s Cardiovascular Health: Prioritizing the Majority Minority
Women make up the majority of the global population, and
- Open Access
- 15 November 2022
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 9 (11) , 394
Association between Abnormal Echocardiography and Adverse Obstetric Outcomes in Low-Risk Pregnant Women
Maternal mortality in the United States is a public health crisis of preventable deaths among young women. The role of echocardiography in the evaluation of pregnant women with cardiovascular symptoms or risk factors without known heart disease is unclear. We retrospectively examined the clinical characteristics of consecutive pregnant patients without established heart disease who underwent echocardiography and evaluated associations between abnormal exam findings and obstetric outcomes. Among low-risk women undergoing echocardiography during pregnancy, older age, higher parity and a history of chronic hypertension are associated with a higher likelihood of echocardiographic abnormalities, which in turn are associated with a higher likelihood of adverse obstetric outcomes including caesarean section and preterm delivery.
- 15 November 2022
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 9 (11) , 394
Open AccessAssociation between Abnormal Echocardiography and Adverse Obstetric Outcomes in Low-Risk Pregnant Women
Maternal mortality in the United States is a public health crisis of preventable deaths among young women. The role of echocardiography in the evaluation of pregnant women with cardiovascular symptoms or risk factors without known heart disease is unclear. We retrospectively examined the clinical characteristics of consecutive pregnant patients without established heart disease who underwent echocardiography and evaluated associations between abnormal exam findings and obstetric outcomes. Among low-risk women undergoing echocardiography during pregnancy, older age, higher parity and a history of chronic hypertension are associated with a higher likelihood of echocardiographic abnormalities, which in turn are associated with a higher likelihood of adverse obstetric outcomes including caesarean section and preterm delivery.